Clinical Trial Update: Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia

View source ↗

Summary

Post-marketing surveillance results for Roxadustat (EVRENZO) in patients with renal anemia; the study has completed and results have been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Anemia

Drugs mentioned

• EVRENZO (roxadustat)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Renal Anemia | Status: COMPLETED